Rod Hicks
Rod Hicks
Professor of Medicine, the Sir Peter MacCallum Department of Oncology, the University of Melbourne
Verified email at petermac.org
Title
Cited by
Cited by
Year
Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma
ME Juweid, S Stroobants, OS Hoekstra, FM Mottaghy, M Dietlein, ...
Journal of clinical oncology 25 (5), 571-578, 2007
14642007
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group
SF Barrington, NG Mikhaeel, L Kostakoglu, M Meignan, M Hutchings, ...
Journal of clinical oncology 32 (27), 3048, 2014
10272014
Delivering affordable cancer care in high-income countries
R Sullivan, J Peppercorn, K Sikora, J Zalcberg, NJ Meropol, E Amir, ...
The lancet oncology 12 (10), 933-980, 2011
6682011
Prognostic Significance of [18F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer …
D Rischin, RJ Hicks, R Fisher, D Binns, J Corry, S Porceddu, LJ Peters
Journal of Clinical Oncology 24 (13), 2098-2104, 2006
5212006
Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non–small-cell …
MP Mac Manus, RJ Hicks, JP Matthews, A McKenzie, D Rischin, ...
Journal of Clinical Oncology 21 (7), 1285-1292, 2003
4762003
Evaluation of circulating tumor cells and circulating tumor DNA in non–small cell lung cancer: Association with clinical endpoints in a phase II clinical trial of pertuzumab …
EA Punnoose, S Atwal, W Liu, R Raja, BM Fine, BGM Hughes, RJ Hicks, ...
Clinical Cancer Research 18 (8), 2391-2401, 2012
4092012
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
MS Hofman, J Violet, RJ Hicks, J Ferdinandus, SP Thang, T Akhurst, ...
The Lancet Oncology 19 (6), 825-833, 2018
3532018
High rate of detection of unsuspected distant metastases by PET in apparent Stage III non–small-cell lung cancer: implications for radical radiation therapy
MP Mac Manus, RJ Hicks, JP Matthews, A Hogg, AF McKenzie, A Wirth, ...
International Journal of Radiation Oncology* Biology* Physics 50 (2), 287-293, 2001
3322001
MRI-negative PET-positive temporal lobe epilepsy: a distinct surgically remediable syndrome
RP Carne, TJ O'brien, CJ Kilpatrick, LR MacGregor, RJ Hicks, MA Murphy, ...
Brain 127 (10), 2276-2285, 2004
3292004
90Y-edotreotide for metastatic carcinoid refractory to octreotide
DL Bushnell Jr, TM O'Dorisio, MS O'Dorisio, Y Menda, RJ Hicks, ...
Journal of Clinical Oncology 28 (10), 1652, 2010
3232010
Clinical Impact of 18F Fluorodeoxyglucose Positron Emission Tomography in Patients With Non–Small-Cell Lung Cancer: A Prospective Study
V Kalff, RJ Hicks, M P. MacManus, DS Binns, AF McKenzie, RE Ware, ...
Journal of clinical oncology 19 (1), 111-118, 2001
2842001
18F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non–small cell lung cancer
RJ Hicks, V Kalff, MP MacManus, RE Ware, A Hogg, AF McKenzie, ...
Journal of Nuclear Medicine 42 (11), 1596-1604, 2001
2832001
Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo) radiotherapy in head and neck cancer
SV Porceddu, E Jarmolowski, RJ Hicks, R Ware, LA Weih, D Rischin, ...
Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2005
2702005
F‐18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high …
MP Mac Manus, RJ Hicks, DL Ball, V Kalff, JP Matthews, E Salminen, ...
Cancer 92 (4), 886-895, 2001
2652001
Somatostatin Receptor Imaging with 68Ga DOTATATE PET/CT: Clinical Utility, Normal Patterns, Pearls, and Pitfalls in Interpretation
MS Hofman, WFE Lau, RJ Hicks
Radiographics 35 (2), 500-516, 2015
2502015
Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer
D Rischin, L Peters, R Hicks, P Hughes, R Fisher, R Hart, M Sexton, ...
Journal of Clinical Oncology 19 (2), 535-542, 2001
2322001
The utility of 18F-FDG PET for suspected recurrent non–small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification
RJ Hicks, V Kalff, MP MacManus, RE Ware, AF McKenzie, JP Matthews, ...
Journal of Nuclear Medicine 42 (11), 1605-1613, 2001
2252001
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin’s disease and non-Hodgkin’s lymphoma
A Wirth, JF Seymour, RJ Hicks, R Ware, R Fisher, M Prince, ...
The American journal of medicine 112 (4), 262-268, 2002
2202002
Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization.
J vom Dahl, DT Eitzman, ZR Al-Aouar, HL Kanter, RJ Hicks, GM Deeb, ...
Circulation 90 (5), 2356-2366, 1994
2191994
The clinical impact of 18F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study
V Kalff, RJ Hicks, RE Ware, A Hogg, D Binns, AF McKenzie
Journal of Nuclear Medicine 43 (4), 492-499, 2002
2082002
The system can't perform the operation now. Try again later.
Articles 1–20